US And European Advisory Panels To Discuss Avnadia’s (Rosiglitazone) Safety
Jul 11th, 2010 | By buddy1 | Category: Diseases, Disorders, Infections, Health & Wellness NewsAs the FDA (Food and Drug Administration) advisory panel prepares to meet next week to discuss the safety of Avandia (Rosiglitazone), an anti-diabetic insulin sensitizer drug, FDA scientists continue to question its safety. The endocrinologic and metabolic advisory committees meet this Wednesday. They will also vote on whether they think the drug should remain on [...] Read more »



